{
  "id": 10766,
  "url": "https://thenextweb.com/news/miles-wang-openai-ai-drug-discovery-startup",
  "title": "An OpenAI researcher is leaving to build a $2bn AI drug startup that has no name yet",
  "summary": "No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise about $200m at a $2bn valuation, with Lightspeed in […] This story continues at The Next Web",
  "authors": "Cristian Dina",
  "category": "news",
  "topics": "healthcare,finance-investment,biotech",
  "orgs": "openai",
  "regions": null,
  "published_at": "2026-07-15T20:33:30.000Z",
  "fetched_at": "2026-07-16T05:10:56.605Z",
  "source_slug": "x-the-next-web-ai",
  "source_name": "The Next Web AI",
  "source_homepage": "https://thenextweb.com/topic/artificial-intelligence",
  "ethics_ai_record_url": "https://ethics.ai/record/10766",
  "original_url": "https://thenextweb.com/news/miles-wang-openai-ai-drug-discovery-startup",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}